|
Volumn 6, Issue 1, 2008, Pages 83-99
|
Pharmacologic options for CNS infections caused by resistant Gram-positive organisms
|
Author keywords
CNS infection; Daptomycin; Linezolid; Meningitis; MRSA; Quinupristin dalfopristin; Tigecycline; Vancomycin; Ventriculitis; VRE
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
CEFAZOLIN;
CEFOTAXIME;
CEFTAZIDIME;
CEFTOBIPROLE;
CEFTRIAXONE;
CEPHALOSPORIN DERIVATIVE;
CHLORAMPHENICOL;
COTRIMOXAZOLE;
CREATININE;
DALBAVANCIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
DAPTOMYCIN;
DEXAMETHASONE;
ICLAPRIM;
LINEZOLID;
METICILLIN;
MINOCYCLINE;
ORITAVANCIN;
PENICILLIN DERIVATIVE;
RIFAMPICIN;
TELAVANCIN;
TETRACYCLINE;
TIGECYCLINE;
VANCOMYCIN;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
BACTERIAL MENINGITIS;
BACTERIAL SKIN DISEASE;
BLOOD BRAIN BARRIER;
CENTRAL NERVOUS SYSTEM INFECTION;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CREATININE BLOOD LEVEL;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG CEREBROSPINAL FLUID LEVEL;
DRUG DOSE COMPARISON;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG MEGADOSE;
DRUG PENETRATION;
DRUG POTENCY;
DRUG PROTEIN BINDING;
DRUG SAFETY;
DRUG SUBSTITUTION;
DRUG TREATMENT FAILURE;
DRUG URINE LEVEL;
DRUG WITHDRAWAL;
EVIDENCE BASED MEDICINE;
GRAM POSITIVE BACTERIUM;
HUMAN;
LOW DRUG DOSE;
MINIMUM INHIBITORY CONCENTRATION;
MONOTHERAPY;
MULTIDRUG RESISTANCE;
NONHUMAN;
PHARMACODYNAMICS;
POSTOPERATIVE INFECTION;
QT INTERVAL;
REVIEW;
SIDE EFFECT;
SINGLE DRUG DOSE;
UNSPECIFIED SIDE EFFECT;
|
EID: 40649123588
PISSN: 14787210
EISSN: 17448336
Source Type: Journal
DOI: 10.1586/14787210.6.1.83 Document Type: Review |
Times cited : (15)
|
References (133)
|